SLC7A11 and chronic myelogenous leukemia, BCR-ABL1 positive: Similarly, Hyperoside induces ferroptosis in chronic myeloid leukemia cells by targeting the Nrf2/SLC7A11/GPX4 axis, with molecular docking, DARTS, and CETSA experiments demonstrating its high affinity for Nrf2 (Wei et al., 2024).